The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa
Open accessAbstract
Opportunistic infections are often polymicrobial. Two of the most important bacterial opportunistic pathogens of humans, Pseudomonas aeruginosa and Staphylococcus aureus , frequently are coisolated from infections of catheters, endotracheal tubes, skin, eyes, and the respiratory tract, including the airways of people with cystic fibrosis (CF). Here, we show that suppression of S. aureus respiration by a P. aeruginosa exoproduct, 4-hydroxy-2-heptylquinoline- N -oxide (HQNO), protects S. aureus during coculture from killing by commonly used aminoglycoside antibiotics such as tobramycin. Furthermore, prolonged growth of S. aureus with either P. aeruginosa or with physiological concentrations of pure HQNO selects for typical S. aureus small-colony variants (SCVs), well known for stable aminoglycoside resistance and persistence in chronic infections, including those found in CF. We detected HQNO in the sputum of CF patients infected with P. aeruginosa , but not in uninfected patients, suggesting that this HQNO-mediated interspecies interaction occurs in CF airways. Thus, in all coinfections with P. aeruginosa , S. aureus may be underappreciated as a pathogen because of the formation of antibiotic-resistant and difficult to detect small-colony variants. Interspecies microbial interactions, analogous to those mediated by HQNO, commonly may alter not only the course of disease and the response to therapy, but also the population structure of bacterial communities that promote the health of host animals, plants, and ecosystems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure to an HQNO source suppresses the growth of S. aureus, resulting in small colonies which are easily missed in diagnostic cultures (Hoffman et al., 2006).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Hoffman et al., 2006
In the citing paper
“Furthermore, HQNO can be detected at active concentrations in the sputum of CF patients infected with P. aeruginosa, suggesting that HQNO has the same effect in the lungs of CF patients as it has in vitro (Hoffman et al., 2006).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Hoffman et al., 2006
In the citing paper
“Prolonged co-culture with P. aeruginosa or exposure to pure HQNO leads to a high proportion of stable S. aureus SCVs, an effect that is increased by the presence of aminoglycosides (Hoffman et al., 2006).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Hoffman et al., 2006
In the citing paper
“Remarkably, the switch to a SCV phenotype increases survival of S. aureus in unfavorable conditions as it exhibits an increased aminoglycoside resistance, biofilm formation, and intracellular survival (Hoffman et al., 2006; Proctor et al., 2006; Biswas et al., 2009; Atalla et al., 2011).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Hoffman et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Ventilator-associated Pneumonia
Chastre, J., & Fagon, J.-Y. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2105078 · Cited by 2,812
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Self-citationAminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
Self-citationProctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Molecular analysis of the bacterial microbiota in the human stomach
Bik, E. M., Eckburg, P. B., Gill, S. R., Nelson, K. E., Purdom, E. A., Francois, F., Perez-Perez, G., Blaser, M. J., & Relman, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506655103 · Cited by 1,158
Déziel, E., Lépine, F., Milot, S., He, J., Mindrinos, M. N., Tompkins, R. G., & Rahme, L. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307694100 · Cited by 637
Self-citationPseudomonas - Candida Interactions: An Ecological Role for Virulence Factors
Hogan, D. A., & Kolter, R. (2002) · Science · doi:10.1126/science.1070784 · Cited by 579
Functions Required for Extracellular Quinolone Signaling by Pseudomonas aeruginosa
Gallagher, L. A., McKnight, S. L., Kuznetsova, M. S., Pesci, E. C., & Manoil, C. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6472-6480.2002 · Cited by 552
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., Ramsey, B. W., & Clausen, C. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514631 · Cited by 421
Self-citationAutolysis and Autoaggregation in Pseudomonas aeruginosa Colony Morphology Mutants
D'Argenio, D. A., Calfee, M. W., Rainey, P. B., & Pesci, E. C. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6481-6489.2002 · Cited by 416
Self-citationHuman polymicrobial infections
BROGDEN, K., Guthmiller, J. M., & TAYLOR, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17745-9 · Cited by 370
Kahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Staphylococcus aureus Serves as an Iron Source for Pseudomonas aeruginosa during In Vivo Coculture
Mashburn, L. M., Jett, A. M., Akins, D. R., & Whiteley, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.2.554-566.2005 · Cited by 312
Lépine, F., Milot, S., Déziel, E., He, J., & Rahme, L. G. (2004) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2004.02.012 · Cited by 250
Self-citationBalwit, J. M., Langevelde, P. V., Vann, J. M., & Proctor, R. A. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.4.1033 · Cited by 237
An, D., Danhorn, T., Fuqua, C., & Parsek, M. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511323103 · Cited by 221
Yim, G., Huimi Wang, H., & Davies, J. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.01.039 · Cited by 208
Lightbown, J. W., & Jackson, F. L. (1956) · Biochemical Journal · doi:10.1042/bj0630130 · Cited by 205
A bacterial cell to cell signal in the lungs of cystic fibrosis patients
Collier, D. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(02)00937-0 · Cited by 192
2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa
Machan, Z. A., Taylor, G. W., Pitt, T. L., Cole, P. J., & Wilson, R. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.5.615 · Cited by 188
The small colony variant (SCV) concept—the role of staphylococcal SCVs in persistent infections
von Eiff, C., Peters, G., & Becker, K. (2006) · Injury · doi:10.1016/j.injury.2006.04.006 · Cited by 180
Straight, P. D., Willey, J. M., & Kolter, R. (2006) · Journal of Bacteriology · doi:10.1128/jb.00162-06 · Cited by 147
Miller, M. H., Edberg, S. C., Mandel, L., Behar, C. F., & Steigbigel, N. H. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.5.722 · Cited by 144
Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa
Häußler, S. (2004) · Environmental Microbiology · doi:10.1111/j.1462-2920.2004.00618.x · Cited by 143
Lepine, F. L., Déziel, É., Milot, S. M., et al. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00103-x · Cited by 142
Assessment of a simple, non‐toxic alamar blue cell survival assay to monitor tomato cell viability
Byth, H., Mchunu, B. I., Dubery, I. A., & Bornman, L. (2001) · Phytochemical Analysis · doi:10.1002/pca.595 · Cited by 81
Staphylococcus aureus small colony variants: formation and clinical impact.
von Eiff, C., Proctor, R. A., & Peters, G. (2000) · PubMed · Cited by 52
Virulent gentamicin-induced small colony variants of Staphylococcus aureus.
Pelletier, L. L., Richardson, M., & Feist, M. D. (1979) · PubMed · Cited by 46
Small-colony variants of Staphylococcus aureus.
Looney, W. J. (2000) · PubMed · Cited by 40
Prophylactic Antibiotics in Cystic Fibrosis: A Conviction without Evidence?
Smyth, A. R. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20305 · Cited by 35
Cited by
Rampersad, S. N. (2012) · Sensors · doi:10.3390/s120912347 · Cited by 1,068
A Type VI Secretion System of Pseudomonas aeruginosa Targets a Toxin to Bacteria
Hood, R. D., Singh, P., Hsu, F., Güvener, T., Carl, M. A., Trinidad, R. R. S., Silverman, J. M., Ohlson, B. B., Hicks, K. G., Plemel, R. L., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2009.12.007 · Cited by 932
Williams, P., & Cámara, M. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.01.005 · Cited by 793
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
Multi-species biofilms: living with friendly neighbors
Elias, S., & Banin, E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00325.x · Cited by 762
Metadata
- Authors
- Hoffman, L. R., Déziel, E., D'Argenio, D. A., Lépine, F., Emerson, J., McNamara, S., Gibson, R. L., Ramsey, B. W., & Miller, S. I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-12-26
- Volume
- 103
- Issue
- 52
- Pages
- 19890-19895
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2147898933
- Cited by
- 467
- References
- 31
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.